Food And Drug Administration Decides To Forego Fosamax Investigation
In light with the Fosamax lawsuit filed against Fosamax’s producer ,Merck, a safety announcement regarding bisphosphonates’ possible link with atypical low-impact femur fractures was divulged by the U.S. Food and Drug Administration (FDA) last March 10, 2011 .
In the given safety notice, FDA declared:
“At this point, the data that FDA [...]